Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma
PHASE2
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
PHASE3
This phase III trial studies how well chemotherapy and radiation therapy (c...
High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
PHASE2
This randomized phase II trial studies how well high or standard intensity ...
Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
PHASE2
RATIONALE: Fosaprepitant dimeglumine, palonosetron hydrochloride, and dexam...
Status
Terminated
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium